Cisbio to sell Fujirebio mesothelioma test in France
This article was originally published in Clinica
Executive Summary
Fujirebio Diagnostics has signed a deal with French biotech firm Cisbio international, which will see its Mesomark blood test for mesothelioma enter its second market. The product has already been launched through a distributor in Australia.